Skip to main content
. Author manuscript; available in PMC: 2015 Jun 23.
Published in final edited form as: Vaccine. 2007 Jan 30;25(16):2984–2989. doi: 10.1016/j.vaccine.2007.01.063

Figure 2.

Figure 2

Neuraminidase (NA) construct characterization. Figure 2a shows S35-labeled in vitro translation of the synthesized construct. The antigen was translated and run on a 12% SDS gel, and subject to radiographic analysis. The antigen runs at its predicted molecular weight, confirming expression. Figure 2b shows a phylogenetic analysis of the consensus construct. The star represents the consensus construct, relative to its component viruses.